Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

LEXICON PHARMACEUTICALS, INC. (LXRX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

LEXICON PHARMACEUTICALS, INC. (LXRX), most recent 12 months reported: revenue $41.47M, net loss $61.12M, free cash flow -$67.85M. Latest balance sheet on file: liquid cash $190.61M, total debt $51.44M, net cash $139.17M. From SEC filings. Others in Pharmaceutical Preparations: OCULAR THERAPEUTIX, INC · Spero Therapeutics, Inc. · Biofrontera Inc. · INTEGRATED BIOPHARMA INC · BGM Group Ltd · Cue Biopharma, Inc. · ZYMEWORKS INC. · Zomedica Corp.

Stock screener

Watchlist